Survival rates of children with cancer continue to increase
The survival rate of children with cancer continues to rise, according to figures published by IKNL. Healthcare professionals and scientists at the Princess Máxima Center remain committed to curing even more children with cancer and improving the quality of life of children and survivors.
Compared to the period 1990-1999, the survival rate of children diagnosed with cancer in 2010 through 2018 is markedly higher. For diagnoses during the latter period, the survival rate was 84 percent, up from 74 percent in the 1990s.
‘It is good to see that survival in childhood cancer has continued to increase,’ Prof. Dr. René Medema, Chief Scientific Officer, says of the new IKNL figures. ‘In several forms of leukemia, such as AML and ALL, we see the largest increase thanks to a sum of many different improvements. But across the board, there are still too many children with an extremely poor prognosis: the most difficult-to-treat tumors remain. That is why it is so important to continue to join forces of healthcare professionals and researchers within the Netherlands, within Europe and worldwide. Only together can we achieve the breakthroughs needed to cure all children with cancer, with optimal quality of life.’
Following the new figures, pediatric oncologist dr. Wouter Kollen and pediatric neurosurgeon prof. dr. Eelco Hoving gave an interview to the AD newspaper. Among other things, they talked about the strides being made with immunotherapy for treatment of leukemia, how new technology lets doctors operate better, and approaches to permanently improve the quality of life of children and survivors.
IKNL’s full press release can be found here. The AD interview is here.
UMC Utrecht takes third surgical robot into use
UMC Utrecht has commissioned a third surgical robot. With the arrival of the latest generation, the Da Vinci 5, even more patients can be operated on with minimal stress. This leads to fewer complications and faster recovery. “Apart from the benefits for patients, the Da Vinci 5 also allows us to train even better,” says Jelle Ruurda, gastrointestinal surgeon and professor of robot-assisted minimally invasive surgery. “At the touch of a button, colleagues can watch remotely, and even learn from previous operations. This way we share knowledge faster and more widely.” The hospital is thus building on a tradition of 25 years at the forefront of robotic surgery.
Kuros signs agreement with USPB
Kuros will expand R&D and manufacturing activities.
Utrecht Science Park Bilthoven (USP Bilthoven), the science park for life science and biomanufacturing companies, has entered into a lease agreement with Kuros Biosciences to support the company’s continued growth and expansion of R&D and manufacturing activities. This milestone agreement underscores USP Bilthoven’s ambition to be a premier destination for companies scaling advanced biomanufacturing and life sciences operations in Europe.
Scientists strip cancer cells of their disguise using sound waves
A combination of immunotherapy and ultrasound appears to be safe and may potentially help treat metastatic cancer in the future. However, research into this new treatment is still in an early stage.
Inspiring and connecting visit by the President of Estonia to Utrecht Science Park
On Wednesday, April 8, 2026, the President of Estonia, Mr. Alar Karis, together with his wife Sirje Karis, ambassador Mr. Paul Teesalu and a delegation from the Estonian Health Ecosystem, visited the Utrecht Science Park. During the visit, much knowledge was exchanged and valuable connections were made.